Shoshanna Solomon is The Times of Israel s Startups and Business reporter
TytoCare, a telehealth startup that has developed an artificial intelligence based device that enables remote medical examinations (YouTube screenshot)
TytoCare, a telehealth startup that has developed an artificial intelligence-based device that enables clinicians to perform remote medical examinations, said Thursday it has raised $50 million in an extension to its Series D fundraising round, doubling the company’s valuation.
This funding comes on the heels of TytoCare raising $50 million in April 2020, bringing the money raised over the last 10 months to $100 million, the startup said in a statement.
Existing investor Insight Partners led the extension round with participation from new investors Tiger Global Management and Qumra Capital and existing investors Qualcomm Ventures LLC, Olive Tree Ventures, and Shenzhen Capital Group Company. With the added funding TytoCare has raised a total of $155 million
Share
TytoCare, a telehealth platform and remote care device maker, has added another $50 million to its Series D funding round, bringing the oversubscribed round to a total of $100 million.
The Israeli startup raised the first $50 million in April 2020 in a round led by Insight Partners, which led this extension as well. New investors Tiger Global Management and Qumra Capital joined this time around, as well as investors from previous rounds, including Qualcomm Ventures, Olive Tree Ventures, and Shenzhen Capital Group Company.
With this addition, TytoCare has secured $155 million in funding to date.
WHAT IT DOES
TytoCare combines remote monitoring and telehealth to allow patients to conduct their own exams at home with the TytoHome kit, while being guided and evaluated by a doctor through its telehealth platform.
IND Approval of Q-1802 from QureBio by FDA prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.